Saltar al contenido
Radio Logo
PodcastsCienciasBiotechTV - News

BiotechTV - News

BiotechTV
BiotechTV - News
Último episodio

489 episodios

  • BiotechTV - News

    London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system

    19/10/2026 | 13 min
    CEO John Baker describes how the project, done in collaboration with Ultima Genomics and Waters Corporation, will give researcher a tool to better understand the immune system. He also describes how IMU's blood sample based system works, and how it has been used for things such as to better understand which patients will respond to cancer immunotherapies.
  • BiotechTV - News

    Oxford, UK based OMass Therapeutics announced a $310M series C today, advancing its small molecule platform, including the lead MC2 (melanocortin-2) receptor antagonist that is in phase 1

    15/10/2026 | 11 min
    CEO Ros Deegan describes the raise and the new investors that it brings into the company, and updates us on the company's pipeline progress.
  • BiotechTV - News

    At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research

    14/10/2026 | 19 min
    They discuss recent advances, what's ahead, Cigall's work in epigenetics, and how a new hospital will be purpose built for patients with the best new technologies in clinical research.
  • BiotechTV - News

    Eli Lilly Chairman & CEO David Ricks discusses GLP-1's, Alzheimer's, business development and more

    07/10/2026 | 23 min
    From the company's headquarters in Indianapolis, he describes where he thinks the obesity field could be headed in the next few years, what might be next after beta-amyloid in Alzheimer's, and how he plans to invest for the future.
  • BiotechTV - News

    After a busy time in Boston during the Aging Research and Drug Discovery Meeting, Insilico Medicine CEO Alex Zhavoronkov discusses the latest in longevity therapeutics and Insilico's pipeline progress

    05/10/2026 | 27 min
    He describes the biomarkers that researchers and investigators have been using, and how large pharma companies like Lilly and Novo Nordisk have begun to embrace the field. Plus, the logevity component Insilico has built into its IPF trials, and what other programs and targets he calls out.
Más podcasts de Ciencias
Acerca de BiotechTV - News
This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
Sitio web del podcast

Escucha BiotechTV - News, Materia Oscura y muchos más podcasts de todo el mundo con la aplicación de radio.es

Descarga la app gratuita: radio.es

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
BiotechTV - News: Podcasts del grupo